A new report commissioned by The Wellcome Trust has identified the factors that enabled vaccines for COVID-19 to be developed and authorized so quickly and effectively.
Mar 11, 2022
0
10
New research in the December 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network found that only 59% of oncology clinical trials studied provided adequately-defined rules for censoring. The researchers ...
Dec 15, 2021
0
1
British pharma giant GlaxoSmithKline and Canada's Medicago said on Tuesday they had seen positive results with a candidate COVID-19 vaccine in a large-scale trial, although the tests were carried out before the Omicron variant ...
Dec 7, 2021
0
2
Australia on Sunday cleared the first COVID-19 vaccine for children aged five to 11, with the next stage of its vaccine rollout expected to start in early 2022.
Dec 5, 2021
0
9
Australia on Wednesday authorised booster shots of COVID-19 vaccines for over-18s, with the third dose expected to be offered to the entire population from next month.
Oct 27, 2021
0
3
Switzerland on Tuesday authorised booster shots of COVID-19 vaccines for the over-65s, as it urged those with no protection at all to get immunised.
Oct 26, 2021
0
2
After several decades of pre-clinical development, cell- and gene-based therapies for Parkinson's disease (PD) are now actively being explored. In this special supplement to the Journal of Parkinson's Disease, "Repairing ...
Sep 24, 2021
0
21
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its COVID vaccine after trial data showed a significant increase in antibodies against ...
Sep 2, 2021
0
6
Switzerland on Monday approved Moderna's COVID-19 vaccine for youngsters aged between 12 and 17 years old, weeks after EU regulators authorised the drug for the same age group.
Aug 9, 2021
0
6
South Africa's resurgence of COVID-19 is setting record numbers of new daily cases, centered in Johannesburg and driven by the delta variant, health officials said Sunday.
Jul 4, 2021
0
3
